Caris Life Sciences (CAI) Goodwill (2024 - 2026)

Caris Life Sciences' (CAI) quarterly Goodwill came in at $19.3 million in Q1 2026, little changed quarter-over-quarter from $19.3 million in Q4 2025.

Caris Life Sciences (CAI) Goodwill (2024 - 2026) Analysis & Trends

Caris Life Sciences' Goodwill history runs 3 years deep, the most recent figure standing at $19.3 million for Q1 2026.

  • On a quarterly basis, Goodwill changed N/A year-over-year to $19.3 million in Q1 2026; TTM through Mar 2026 was $19.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $19.3 million, changed 0.0% from the prior year.
  • Goodwill was little changed at $19.3 million in Q1 2026 per CAI's latest filing, from $19.3 million in the prior quarter.
  • Across five years, Goodwill topped out at $19.3 million in Q4 2024 and bottomed at $19.3 million in Q4 2024.
  • The 3-year median for Goodwill is $19.3 million (2024), against an average of $19.3 million.
  • Biggest YoY gain for Goodwill was 0.0% in 2025; the steepest drop was 0.0% in 2025.
  • Year by year, Goodwill stood at $19.3 million in 2024, then changed by 0.0% to $19.3 million in 2025, then changed by 0.0% to $19.3 million in 2026.
  • Per Business Quant, the three latest CAI Goodwill figures stand at $19.3 million (Q1 2026), $19.3 million (Q4 2025), and $19.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Caris Life Sciences 4.42 Bn 3.60 Bn 214.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.34 Mn
Dec 31, 2025 19.34 Mn
Sep 30, 2025 19.34 Mn
Jun 30, 2025 19.34 Mn
Dec 31, 2024 19.34 Mn